HEADER TRANSFERASE 28-AUG-06 2I6A TITLE HUMAN ADENOSINE KINASE IN COMPLEX WITH 5'-DEOXY-5-IODOTUBERCIDIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENOSINE KINASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: ADENYLATE KINASE; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN-LIGAND COMPLEX, 5'-DEOXY-5-IODOTUBERCIDIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.MUCHMORE REVDAT 4 21-FEB-24 2I6A 1 REMARK REVDAT 3 18-OCT-17 2I6A 1 REMARK REVDAT 2 24-FEB-09 2I6A 1 VERSN REVDAT 1 02-JAN-07 2I6A 0 JRNL AUTH S.W.MUCHMORE,R.A.SMITH,A.O.STEWART,M.D.COWART,A.GOMTSYAN, JRNL AUTH 2 M.A.MATULENKO,H.YU,J.M.SEVERIN,S.S.BHAGWAT,C.H.LEE, JRNL AUTH 3 E.A.KOWALUK,M.F.JARVIS,C.L.JAKOB JRNL TITL CRYSTAL STRUCTURES OF HUMAN ADENOSINE KINASE INHIBITOR JRNL TITL 2 COMPLEXES REVEAL TWO DISTINCT BINDING MODES. JRNL REF J.MED.CHEM. V. 49 6726 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 17154503 JRNL DOI 10.1021/JM060189A REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 85.5 REMARK 3 NUMBER OF REFLECTIONS : 35353 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3516 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10828 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2I6A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039190. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SILICON 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35353 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: DM REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, 0.1 M MGCL2, PH 7.2, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 MET C 1 REMARK 465 THR C 2 REMARK 465 MET D 1 REMARK 465 THR D 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS D 345 O HOH D 531 2.00 REMARK 500 O ILE C 77 N GLN C 79 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 342 C - N - CD ANGL. DEV. = -17.5 DEGREES REMARK 500 PRO B 35 C - N - CD ANGL. DEV. = -19.7 DEGREES REMARK 500 HIS B 81 O - C - N ANGL. DEV. = -10.3 DEGREES REMARK 500 ARG B 258 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 78 -53.99 58.97 REMARK 500 GLN A 79 -98.30 -34.95 REMARK 500 ALA A 139 -110.90 46.72 REMARK 500 HIS A 149 -68.24 -155.37 REMARK 500 SER A 198 -50.58 60.39 REMARK 500 THR A 238 137.83 -176.64 REMARK 500 ASP A 286 49.01 -58.19 REMARK 500 GLN A 287 41.80 -78.66 REMARK 500 ASP A 288 -173.48 -51.98 REMARK 500 GLN A 289 14.10 43.19 REMARK 500 GLU A 291 -88.90 20.98 REMARK 500 ILE A 292 79.98 -68.87 REMARK 500 ASP A 294 96.28 -47.73 REMARK 500 ILE A 330 80.73 -60.34 REMARK 500 PRO A 342 -174.88 -48.20 REMARK 500 ASP A 343 23.20 -155.24 REMARK 500 VAL B 23 -166.76 -119.60 REMARK 500 SER B 32 53.95 39.24 REMARK 500 GLN B 78 -110.63 80.45 REMARK 500 ALA B 139 -106.64 59.77 REMARK 500 CYS B 143 30.10 -96.87 REMARK 500 HIS B 149 -69.91 -149.18 REMARK 500 SER B 198 -54.73 64.18 REMARK 500 ASN B 223 -169.22 -103.40 REMARK 500 ASP B 270 153.43 -46.87 REMARK 500 ASP B 286 63.20 -60.45 REMARK 500 GLN B 287 44.86 -93.27 REMARK 500 ASP B 288 -171.56 -57.82 REMARK 500 GLN B 289 4.42 45.23 REMARK 500 GLU B 291 -97.25 26.37 REMARK 500 ILE B 292 57.38 -60.22 REMARK 500 ASP B 294 105.74 -45.43 REMARK 500 ILE B 329 -72.53 -100.50 REMARK 500 ILE B 330 91.06 -58.86 REMARK 500 ASP B 343 72.89 -116.24 REMARK 500 ALA C 21 146.92 -171.12 REMARK 500 GLU C 42 -137.47 -91.61 REMARK 500 GLN C 78 -60.36 42.10 REMARK 500 GLN C 79 -104.68 -19.59 REMARK 500 ALA C 139 -117.70 40.59 REMARK 500 HIS C 149 -59.37 -166.24 REMARK 500 SER C 198 -57.56 63.33 REMARK 500 GLU C 237 62.12 60.08 REMARK 500 THR C 238 137.19 -177.63 REMARK 500 ASP C 270 139.47 -30.90 REMARK 500 ASP C 286 46.50 -52.02 REMARK 500 GLN C 287 26.95 -74.45 REMARK 500 ASP C 288 178.38 -38.32 REMARK 500 GLN C 289 -8.48 57.68 REMARK 500 GLU C 291 -90.07 33.13 REMARK 500 REMARK 500 THIS ENTRY HAS 74 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5I5 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5I5 B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5I5 C 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5I5 D 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I6B RELATED DB: PDB REMARK 900 2I6B IS THE STRUCTURE OF HUMAN ADENOSINE KINASE IN COMPLEX WITH AN REMARK 900 ACETYLINIC INHIBITOR DBREF 2I6A A 1 345 UNP Q5VXR3 Q5VXR3_HUMAN 1 345 DBREF 2I6A B 1 345 UNP Q5VXR3 Q5VXR3_HUMAN 1 345 DBREF 2I6A C 1 345 UNP Q5VXR3 Q5VXR3_HUMAN 1 345 DBREF 2I6A D 1 345 UNP Q5VXR3 Q5VXR3_HUMAN 1 345 SEQRES 1 A 345 MET THR SER VAL ARG GLU ASN ILE LEU PHE GLY MET GLY SEQRES 2 A 345 ASN PRO LEU LEU ASP ILE SER ALA VAL VAL ASP LYS ASP SEQRES 3 A 345 PHE LEU ASP LYS TYR SER LEU LYS PRO ASN ASP GLN ILE SEQRES 4 A 345 LEU ALA GLU ASP LYS HIS LYS GLU LEU PHE ASP GLU LEU SEQRES 5 A 345 VAL LYS LYS PHE LYS VAL GLU TYR HIS ALA GLY GLY SER SEQRES 6 A 345 THR GLN ASN SER ILE LYS VAL ALA GLN TRP MET ILE GLN SEQRES 7 A 345 GLN PRO HIS LYS ALA ALA THR PHE PHE GLY CYS ILE GLY SEQRES 8 A 345 ILE ASP LYS PHE GLY GLU ILE LEU LYS ARG LYS ALA ALA SEQRES 9 A 345 GLU ALA HIS VAL ASP ALA HIS TYR TYR GLU GLN ASN GLU SEQRES 10 A 345 GLN PRO THR GLY THR CYS ALA ALA CYS ILE THR GLY ASP SEQRES 11 A 345 ASN ARG SER LEU ILE ALA ASN LEU ALA ALA ALA ASN CYS SEQRES 12 A 345 TYR LYS LYS GLU LYS HIS LEU ASP LEU GLU LYS ASN TRP SEQRES 13 A 345 MET LEU VAL GLU LYS ALA ARG VAL CYS TYR ILE ALA GLY SEQRES 14 A 345 PHE PHE LEU THR VAL SER PRO GLU SER VAL LEU LYS VAL SEQRES 15 A 345 ALA HIS HIS ALA SER GLU ASN ASN ARG ILE PHE THR LEU SEQRES 16 A 345 ASN LEU SER ALA PRO PHE ILE SER GLN PHE TYR LYS GLU SEQRES 17 A 345 SER LEU MET LYS VAL MET PRO TYR VAL ASP ILE LEU PHE SEQRES 18 A 345 GLY ASN GLU THR GLU ALA ALA THR PHE ALA ARG GLU GLN SEQRES 19 A 345 GLY PHE GLU THR LYS ASP ILE LYS GLU ILE ALA LYS LYS SEQRES 20 A 345 THR GLN ALA LEU PRO LYS MET ASN SER LYS ARG GLN ARG SEQRES 21 A 345 ILE VAL ILE PHE THR GLN GLY ARG ASP ASP THR ILE MET SEQRES 22 A 345 ALA THR GLU SER GLU VAL THR ALA PHE ALA VAL LEU ASP SEQRES 23 A 345 GLN ASP GLN LYS GLU ILE ILE ASP THR ASN GLY ALA GLY SEQRES 24 A 345 ASP ALA PHE VAL GLY GLY PHE LEU SER GLN LEU VAL SER SEQRES 25 A 345 ASP LYS PRO LEU THR GLU CYS ILE ARG ALA GLY HIS TYR SEQRES 26 A 345 ALA ALA SER ILE ILE ILE ARG ARG THR GLY CYS THR PHE SEQRES 27 A 345 PRO GLU LYS PRO ASP PHE HIS SEQRES 1 B 345 MET THR SER VAL ARG GLU ASN ILE LEU PHE GLY MET GLY SEQRES 2 B 345 ASN PRO LEU LEU ASP ILE SER ALA VAL VAL ASP LYS ASP SEQRES 3 B 345 PHE LEU ASP LYS TYR SER LEU LYS PRO ASN ASP GLN ILE SEQRES 4 B 345 LEU ALA GLU ASP LYS HIS LYS GLU LEU PHE ASP GLU LEU SEQRES 5 B 345 VAL LYS LYS PHE LYS VAL GLU TYR HIS ALA GLY GLY SER SEQRES 6 B 345 THR GLN ASN SER ILE LYS VAL ALA GLN TRP MET ILE GLN SEQRES 7 B 345 GLN PRO HIS LYS ALA ALA THR PHE PHE GLY CYS ILE GLY SEQRES 8 B 345 ILE ASP LYS PHE GLY GLU ILE LEU LYS ARG LYS ALA ALA SEQRES 9 B 345 GLU ALA HIS VAL ASP ALA HIS TYR TYR GLU GLN ASN GLU SEQRES 10 B 345 GLN PRO THR GLY THR CYS ALA ALA CYS ILE THR GLY ASP SEQRES 11 B 345 ASN ARG SER LEU ILE ALA ASN LEU ALA ALA ALA ASN CYS SEQRES 12 B 345 TYR LYS LYS GLU LYS HIS LEU ASP LEU GLU LYS ASN TRP SEQRES 13 B 345 MET LEU VAL GLU LYS ALA ARG VAL CYS TYR ILE ALA GLY SEQRES 14 B 345 PHE PHE LEU THR VAL SER PRO GLU SER VAL LEU LYS VAL SEQRES 15 B 345 ALA HIS HIS ALA SER GLU ASN ASN ARG ILE PHE THR LEU SEQRES 16 B 345 ASN LEU SER ALA PRO PHE ILE SER GLN PHE TYR LYS GLU SEQRES 17 B 345 SER LEU MET LYS VAL MET PRO TYR VAL ASP ILE LEU PHE SEQRES 18 B 345 GLY ASN GLU THR GLU ALA ALA THR PHE ALA ARG GLU GLN SEQRES 19 B 345 GLY PHE GLU THR LYS ASP ILE LYS GLU ILE ALA LYS LYS SEQRES 20 B 345 THR GLN ALA LEU PRO LYS MET ASN SER LYS ARG GLN ARG SEQRES 21 B 345 ILE VAL ILE PHE THR GLN GLY ARG ASP ASP THR ILE MET SEQRES 22 B 345 ALA THR GLU SER GLU VAL THR ALA PHE ALA VAL LEU ASP SEQRES 23 B 345 GLN ASP GLN LYS GLU ILE ILE ASP THR ASN GLY ALA GLY SEQRES 24 B 345 ASP ALA PHE VAL GLY GLY PHE LEU SER GLN LEU VAL SER SEQRES 25 B 345 ASP LYS PRO LEU THR GLU CYS ILE ARG ALA GLY HIS TYR SEQRES 26 B 345 ALA ALA SER ILE ILE ILE ARG ARG THR GLY CYS THR PHE SEQRES 27 B 345 PRO GLU LYS PRO ASP PHE HIS SEQRES 1 C 345 MET THR SER VAL ARG GLU ASN ILE LEU PHE GLY MET GLY SEQRES 2 C 345 ASN PRO LEU LEU ASP ILE SER ALA VAL VAL ASP LYS ASP SEQRES 3 C 345 PHE LEU ASP LYS TYR SER LEU LYS PRO ASN ASP GLN ILE SEQRES 4 C 345 LEU ALA GLU ASP LYS HIS LYS GLU LEU PHE ASP GLU LEU SEQRES 5 C 345 VAL LYS LYS PHE LYS VAL GLU TYR HIS ALA GLY GLY SER SEQRES 6 C 345 THR GLN ASN SER ILE LYS VAL ALA GLN TRP MET ILE GLN SEQRES 7 C 345 GLN PRO HIS LYS ALA ALA THR PHE PHE GLY CYS ILE GLY SEQRES 8 C 345 ILE ASP LYS PHE GLY GLU ILE LEU LYS ARG LYS ALA ALA SEQRES 9 C 345 GLU ALA HIS VAL ASP ALA HIS TYR TYR GLU GLN ASN GLU SEQRES 10 C 345 GLN PRO THR GLY THR CYS ALA ALA CYS ILE THR GLY ASP SEQRES 11 C 345 ASN ARG SER LEU ILE ALA ASN LEU ALA ALA ALA ASN CYS SEQRES 12 C 345 TYR LYS LYS GLU LYS HIS LEU ASP LEU GLU LYS ASN TRP SEQRES 13 C 345 MET LEU VAL GLU LYS ALA ARG VAL CYS TYR ILE ALA GLY SEQRES 14 C 345 PHE PHE LEU THR VAL SER PRO GLU SER VAL LEU LYS VAL SEQRES 15 C 345 ALA HIS HIS ALA SER GLU ASN ASN ARG ILE PHE THR LEU SEQRES 16 C 345 ASN LEU SER ALA PRO PHE ILE SER GLN PHE TYR LYS GLU SEQRES 17 C 345 SER LEU MET LYS VAL MET PRO TYR VAL ASP ILE LEU PHE SEQRES 18 C 345 GLY ASN GLU THR GLU ALA ALA THR PHE ALA ARG GLU GLN SEQRES 19 C 345 GLY PHE GLU THR LYS ASP ILE LYS GLU ILE ALA LYS LYS SEQRES 20 C 345 THR GLN ALA LEU PRO LYS MET ASN SER LYS ARG GLN ARG SEQRES 21 C 345 ILE VAL ILE PHE THR GLN GLY ARG ASP ASP THR ILE MET SEQRES 22 C 345 ALA THR GLU SER GLU VAL THR ALA PHE ALA VAL LEU ASP SEQRES 23 C 345 GLN ASP GLN LYS GLU ILE ILE ASP THR ASN GLY ALA GLY SEQRES 24 C 345 ASP ALA PHE VAL GLY GLY PHE LEU SER GLN LEU VAL SER SEQRES 25 C 345 ASP LYS PRO LEU THR GLU CYS ILE ARG ALA GLY HIS TYR SEQRES 26 C 345 ALA ALA SER ILE ILE ILE ARG ARG THR GLY CYS THR PHE SEQRES 27 C 345 PRO GLU LYS PRO ASP PHE HIS SEQRES 1 D 345 MET THR SER VAL ARG GLU ASN ILE LEU PHE GLY MET GLY SEQRES 2 D 345 ASN PRO LEU LEU ASP ILE SER ALA VAL VAL ASP LYS ASP SEQRES 3 D 345 PHE LEU ASP LYS TYR SER LEU LYS PRO ASN ASP GLN ILE SEQRES 4 D 345 LEU ALA GLU ASP LYS HIS LYS GLU LEU PHE ASP GLU LEU SEQRES 5 D 345 VAL LYS LYS PHE LYS VAL GLU TYR HIS ALA GLY GLY SER SEQRES 6 D 345 THR GLN ASN SER ILE LYS VAL ALA GLN TRP MET ILE GLN SEQRES 7 D 345 GLN PRO HIS LYS ALA ALA THR PHE PHE GLY CYS ILE GLY SEQRES 8 D 345 ILE ASP LYS PHE GLY GLU ILE LEU LYS ARG LYS ALA ALA SEQRES 9 D 345 GLU ALA HIS VAL ASP ALA HIS TYR TYR GLU GLN ASN GLU SEQRES 10 D 345 GLN PRO THR GLY THR CYS ALA ALA CYS ILE THR GLY ASP SEQRES 11 D 345 ASN ARG SER LEU ILE ALA ASN LEU ALA ALA ALA ASN CYS SEQRES 12 D 345 TYR LYS LYS GLU LYS HIS LEU ASP LEU GLU LYS ASN TRP SEQRES 13 D 345 MET LEU VAL GLU LYS ALA ARG VAL CYS TYR ILE ALA GLY SEQRES 14 D 345 PHE PHE LEU THR VAL SER PRO GLU SER VAL LEU LYS VAL SEQRES 15 D 345 ALA HIS HIS ALA SER GLU ASN ASN ARG ILE PHE THR LEU SEQRES 16 D 345 ASN LEU SER ALA PRO PHE ILE SER GLN PHE TYR LYS GLU SEQRES 17 D 345 SER LEU MET LYS VAL MET PRO TYR VAL ASP ILE LEU PHE SEQRES 18 D 345 GLY ASN GLU THR GLU ALA ALA THR PHE ALA ARG GLU GLN SEQRES 19 D 345 GLY PHE GLU THR LYS ASP ILE LYS GLU ILE ALA LYS LYS SEQRES 20 D 345 THR GLN ALA LEU PRO LYS MET ASN SER LYS ARG GLN ARG SEQRES 21 D 345 ILE VAL ILE PHE THR GLN GLY ARG ASP ASP THR ILE MET SEQRES 22 D 345 ALA THR GLU SER GLU VAL THR ALA PHE ALA VAL LEU ASP SEQRES 23 D 345 GLN ASP GLN LYS GLU ILE ILE ASP THR ASN GLY ALA GLY SEQRES 24 D 345 ASP ALA PHE VAL GLY GLY PHE LEU SER GLN LEU VAL SER SEQRES 25 D 345 ASP LYS PRO LEU THR GLU CYS ILE ARG ALA GLY HIS TYR SEQRES 26 D 345 ALA ALA SER ILE ILE ILE ARG ARG THR GLY CYS THR PHE SEQRES 27 D 345 PRO GLU LYS PRO ASP PHE HIS HET 5I5 A 500 19 HET 5I5 B 500 19 HET 5I5 C 500 19 HET 5I5 D 500 19 HETNAM 5I5 7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3- HETNAM 2 5I5 D]PYRIMIDIN-4-AMINE HETSYN 5I5 5'-DEOXY-5-IODOTUBERCIDIN; (2R,3R,4S,5R)-2-(4-AMINO-5- HETSYN 2 5I5 IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-(METHYL) HETSYN 3 5I5 TETRAHYDROFURAN-3,4-DIOL FORMUL 5 5I5 4(C11 H13 I N4 O3) FORMUL 9 HOH *510(H2 O) HELIX 1 1 ASP A 24 TYR A 31 1 8 HELIX 2 2 GLU A 42 LYS A 44 5 3 HELIX 3 3 HIS A 45 PHE A 56 1 12 HELIX 4 4 GLY A 64 GLN A 78 1 15 HELIX 5 5 ASP A 93 GLU A 105 1 13 HELIX 6 6 LEU A 138 TYR A 144 5 7 HELIX 7 7 LEU A 152 GLU A 160 1 9 HELIX 8 8 PHE A 170 VAL A 174 5 5 HELIX 9 9 SER A 175 ASN A 189 1 15 HELIX 10 10 ALA A 199 TYR A 206 1 8 HELIX 11 11 TYR A 206 MET A 214 1 9 HELIX 12 12 PRO A 215 VAL A 217 5 3 HELIX 13 13 GLU A 224 GLY A 235 1 12 HELIX 14 14 ASP A 240 ALA A 250 1 11 HELIX 15 15 ASP A 294 VAL A 311 1 18 HELIX 16 16 PRO A 315 ILE A 330 1 16 HELIX 17 17 ASP B 24 TYR B 31 1 8 HELIX 18 18 GLU B 42 LYS B 44 5 3 HELIX 19 19 HIS B 45 PHE B 56 1 12 HELIX 20 20 GLY B 64 GLN B 78 1 15 HELIX 21 21 ASP B 93 GLU B 105 1 13 HELIX 22 22 ALA B 140 TYR B 144 5 5 HELIX 23 23 LYS B 145 HIS B 149 5 5 HELIX 24 24 LEU B 152 ALA B 162 1 11 HELIX 25 25 PHE B 170 VAL B 174 5 5 HELIX 26 26 SER B 175 ASN B 189 1 15 HELIX 27 27 ALA B 199 TYR B 206 1 8 HELIX 28 28 TYR B 206 MET B 214 1 9 HELIX 29 29 PRO B 215 VAL B 217 5 3 HELIX 30 30 GLU B 224 GLY B 235 1 12 HELIX 31 31 ASP B 240 ALA B 250 1 11 HELIX 32 32 ASP B 294 VAL B 311 1 18 HELIX 33 33 PRO B 315 ILE B 330 1 16 HELIX 34 34 ASP C 24 TYR C 31 1 8 HELIX 35 35 HIS C 45 PHE C 56 1 12 HELIX 36 36 GLY C 64 GLN C 78 1 15 HELIX 37 37 ASP C 93 ALA C 106 1 14 HELIX 38 38 LEU C 138 TYR C 144 5 7 HELIX 39 39 LEU C 152 ALA C 162 1 11 HELIX 40 40 PHE C 170 VAL C 174 5 5 HELIX 41 41 SER C 175 ASN C 189 1 15 HELIX 42 42 ALA C 199 TYR C 206 1 8 HELIX 43 43 TYR C 206 MET C 214 1 9 HELIX 44 44 PRO C 215 VAL C 217 5 3 HELIX 45 45 GLU C 224 GLN C 234 1 11 HELIX 46 46 ASP C 240 ALA C 250 1 11 HELIX 47 47 ASP C 294 VAL C 311 1 18 HELIX 48 48 PRO C 315 ILE C 330 1 16 HELIX 49 49 ASP D 24 TYR D 31 1 8 HELIX 50 50 GLU D 42 LYS D 44 5 3 HELIX 51 51 HIS D 45 PHE D 56 1 12 HELIX 52 52 GLY D 64 GLN D 78 1 15 HELIX 53 53 ASP D 93 ALA D 106 1 14 HELIX 54 54 LEU D 138 TYR D 144 5 7 HELIX 55 55 LYS D 145 HIS D 149 5 5 HELIX 56 56 LEU D 152 ALA D 162 1 11 HELIX 57 57 PHE D 170 VAL D 174 5 5 HELIX 58 58 SER D 175 ASN D 189 1 15 HELIX 59 59 ALA D 199 TYR D 206 1 8 HELIX 60 60 TYR D 206 MET D 214 1 9 HELIX 61 61 PRO D 215 VAL D 217 5 3 HELIX 62 62 GLU D 224 GLN D 234 1 11 HELIX 63 63 ASP D 240 ALA D 250 1 11 HELIX 64 64 ASP D 294 VAL D 311 1 18 HELIX 65 65 PRO D 315 ILE D 330 1 16 SHEET 1 A 9 ASP A 109 GLN A 115 0 SHEET 2 A 9 ALA A 84 GLY A 91 1 N PHE A 86 O HIS A 111 SHEET 3 A 9 LEU A 9 MET A 12 1 N LEU A 9 O THR A 85 SHEET 4 A 9 VAL A 164 ALA A 168 1 O TYR A 166 N PHE A 10 SHEET 5 A 9 ILE A 192 ASN A 196 1 O ILE A 192 N CYS A 165 SHEET 6 A 9 ILE A 219 ASN A 223 1 O ILE A 219 N LEU A 195 SHEET 7 A 9 ILE A 261 GLN A 266 1 O ILE A 261 N LEU A 220 SHEET 8 A 9 ASP A 269 ALA A 274 -1 O ILE A 272 N PHE A 264 SHEET 9 A 9 VAL A 279 PHE A 282 -1 O THR A 280 N MET A 273 SHEET 1 B 5 ASP A 37 LEU A 40 0 SHEET 2 B 5 ASN A 131 ASN A 137 1 O LEU A 134 N ASP A 37 SHEET 3 B 5 GLY A 121 THR A 128 -1 N THR A 122 O ASN A 137 SHEET 4 B 5 LEU A 16 VAL A 22 1 N ILE A 19 O CYS A 123 SHEET 5 B 5 GLU A 59 ALA A 62 -1 O HIS A 61 N ASP A 18 SHEET 1 C 9 ASP B 109 GLN B 115 0 SHEET 2 C 9 ALA B 84 GLY B 91 1 N GLY B 88 O TYR B 113 SHEET 3 C 9 LEU B 9 MET B 12 1 N LEU B 9 O THR B 85 SHEET 4 C 9 VAL B 164 ALA B 168 1 O VAL B 164 N PHE B 10 SHEET 5 C 9 ILE B 192 ASN B 196 1 O ILE B 192 N CYS B 165 SHEET 6 C 9 ILE B 219 ASN B 223 1 O PHE B 221 N LEU B 195 SHEET 7 C 9 ILE B 261 GLN B 266 1 O ILE B 263 N LEU B 220 SHEET 8 C 9 ASP B 269 ALA B 274 -1 O ILE B 272 N PHE B 264 SHEET 9 C 9 VAL B 279 PHE B 282 -1 O THR B 280 N MET B 273 SHEET 1 D 5 ASP B 37 LEU B 40 0 SHEET 2 D 5 ASN B 131 ASN B 137 1 O LEU B 134 N ILE B 39 SHEET 3 D 5 GLY B 121 THR B 128 -1 N THR B 122 O ASN B 137 SHEET 4 D 5 LEU B 16 VAL B 22 1 N ILE B 19 O CYS B 123 SHEET 5 D 5 GLU B 59 ALA B 62 -1 O HIS B 61 N ASP B 18 SHEET 1 E 9 ASP C 109 GLN C 115 0 SHEET 2 E 9 ALA C 84 GLY C 91 1 N GLY C 88 O TYR C 113 SHEET 3 E 9 LEU C 9 MET C 12 1 N LEU C 9 O THR C 85 SHEET 4 E 9 VAL C 164 ALA C 168 1 O TYR C 166 N PHE C 10 SHEET 5 E 9 ILE C 192 ASN C 196 1 O ILE C 192 N CYS C 165 SHEET 6 E 9 ILE C 219 ASN C 223 1 O PHE C 221 N LEU C 195 SHEET 7 E 9 ILE C 261 GLN C 266 1 O ILE C 263 N LEU C 220 SHEET 8 E 9 ASP C 269 ALA C 274 -1 O ILE C 272 N PHE C 264 SHEET 9 E 9 VAL C 279 PHE C 282 -1 O THR C 280 N MET C 273 SHEET 1 F 5 ASP C 37 LEU C 40 0 SHEET 2 F 5 ASN C 131 ASN C 137 1 O LEU C 134 N ILE C 39 SHEET 3 F 5 GLY C 121 THR C 128 -1 N THR C 128 O ASN C 131 SHEET 4 F 5 LEU C 16 VAL C 22 1 N ILE C 19 O CYS C 123 SHEET 5 F 5 GLU C 59 GLY C 63 -1 O HIS C 61 N ASP C 18 SHEET 1 G 9 ASP D 109 GLN D 115 0 SHEET 2 G 9 ALA D 84 GLY D 91 1 N PHE D 86 O HIS D 111 SHEET 3 G 9 LEU D 9 MET D 12 1 N LEU D 9 O THR D 85 SHEET 4 G 9 VAL D 164 ALA D 168 1 O TYR D 166 N PHE D 10 SHEET 5 G 9 ILE D 192 ASN D 196 1 O ILE D 192 N CYS D 165 SHEET 6 G 9 ILE D 219 ASN D 223 1 O PHE D 221 N LEU D 195 SHEET 7 G 9 ILE D 261 GLN D 266 1 O ILE D 261 N LEU D 220 SHEET 8 G 9 ASP D 269 ALA D 274 -1 O ILE D 272 N PHE D 264 SHEET 9 G 9 VAL D 279 PHE D 282 -1 O THR D 280 N MET D 273 SHEET 1 H 5 ASP D 37 LEU D 40 0 SHEET 2 H 5 ASN D 131 ASN D 137 1 O LEU D 134 N ILE D 39 SHEET 3 H 5 THR D 122 THR D 128 -1 N THR D 122 O ASN D 137 SHEET 4 H 5 LEU D 17 VAL D 22 1 N ILE D 19 O ALA D 125 SHEET 5 H 5 GLU D 59 ALA D 62 -1 O GLU D 59 N SER D 20 CISPEP 1 GLN B 79 PRO B 80 0 2.91 SITE 1 AC1 12 ASN A 14 ASP A 18 ILE A 39 LEU A 40 SITE 2 AC1 12 GLY A 63 GLY A 64 SER A 65 ASN A 68 SITE 3 AC1 12 CYS A 123 PHE A 170 ASN A 296 ASP A 300 SITE 1 AC2 12 ASN B 14 ASP B 18 ILE B 39 LEU B 40 SITE 2 AC2 12 GLY B 63 GLY B 64 SER B 65 ASN B 68 SITE 3 AC2 12 ALA B 136 PHE B 170 ASN B 296 ASP B 300 SITE 1 AC3 13 ASN C 14 ASP C 18 ILE C 39 LEU C 40 SITE 2 AC3 13 GLY C 63 GLY C 64 SER C 65 ASN C 68 SITE 3 AC3 13 ALA C 136 LEU C 138 PHE C 170 ASN C 296 SITE 4 AC3 13 ASP C 300 SITE 1 AC4 13 ASN D 14 ASP D 18 ILE D 39 LEU D 40 SITE 2 AC4 13 GLY D 64 SER D 65 ASN D 68 CYS D 123 SITE 3 AC4 13 ALA D 136 PHE D 170 ASN D 296 ASP D 300 SITE 4 AC4 13 HOH D 555 CRYST1 61.850 66.930 87.140 97.76 103.70 89.95 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016168 -0.000014 0.003978 0.00000 SCALE2 0.000000 0.014941 0.002094 0.00000 SCALE3 0.000000 0.000000 0.011927 0.00000